Literature DB >> 30534233

Local injection of tissue-plasminogen activator using a pulse spray catheter as a treatment option for proximal deep vein thrombosis: A case report.

Toshitaka Okabe1, Hiroshi Araki1, Tadayuki Yakushiji1, Seitaro Ebara1, Kennosuke Yamashita1, Myong Hwa Yamamoto1, Shigeo Saito1, Koichi Hoshimoto1, Kisaki Amemiya1, Naoei Isomura1, Chiaki Obara1, Masahiko Ochiai1.   

Abstract

A 24-year-old woman was admitted to our hospital with the diagnosis of pulmonary thromboembolism (PTE) and left common iliac vein thrombosis. She had used low-dose contraceptive pill for dysmenorrhea. Otherwise, her laboratory data did not show any other thrombotic risk factors. Thrombus in the common iliac vein usually requires a permanent inferior vena cava (IVC) filter. However, the use of long-term warfarin should have been avoided for her potential future pregnancy. A retrievable IVC filter was placed and catheter directed thrombolysis was performed for her deep vein thrombosis (DVT). Local injection of monteplase from a pulse spray catheter was performed for 4 days. After the catheter-based treatment, the thrombus resolved and the IVC filter was successfully removed on day 19. The patient was discharged on day 21. Warfarin therapy was discontinued 6 months after discharge. <Learning objective: Urokinase is recommended in the guideline of the Japanese Circulation Society. But the dose is much less than those stated in guidelines overseas. Several studies have shown that tissue-plasminogen activator (t-PA) might be more effective than urokinase. We report a case in which local injection of monteplase, a type of long acting t-PA, for DVT was effective in treating PTE and DVT.>.

Entities:  

Keywords:  Catheter directed thrombolysis; Deep vein thrombosis; Tissue-plasminogen activator; Urokinase

Year:  2014        PMID: 30534233      PMCID: PMC6279535          DOI: 10.1016/j.jccase.2014.05.011

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Short- and long-term results after thrombolytic treatment of deep venous thrombosis.

Authors:  J Schweizer; W Kirch; R Koch; H Elix; G Hellner; L Forkmann; A Graf
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

2.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

3.  Long-term retrieval success rate profile for the Günther Tulip vena cava filter.

Authors:  H Bob Smouse; David Rosenthal; Van Ha Thuong; Michael F Knox; Robert G Dixon; William D Voorhees; Jennifer A McCann-Brown
Journal:  J Vasc Interv Radiol       Date:  2009-05-28       Impact factor: 3.464

4.  Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.

Authors:  S Z Goldhaber; M F Meyerovitz; D Green; R L Vogelzang; P Citrin; J Heit; M Sobel; H B Wheeler; D Plante; H Kim
Journal:  Am J Med       Date:  1990-03       Impact factor: 4.965

5.  Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009).

Authors: 
Journal:  Circ J       Date:  2011-03-25       Impact factor: 2.993

6.  Aspirin for preventing the recurrence of venous thromboembolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Alessandro Schenone; Sabine Eichinger; Eugenio Bucherini; Mauro Silingardi; Marina Bianchi; Marco Moia; Walter Ageno; Maria Rita Vandelli; Elvira Grandone; Paolo Prandoni
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

Review 7.  Plasminogen activators: a comparison.

Authors:  Dev B Baruah; Rajendra N Dash; M R Chaudhari; S S Kadam
Journal:  Vascul Pharmacol       Date:  2005-11-07       Impact factor: 5.773

8.  Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis.

Authors:  K Ouriel; E L Welch; C K Shortell; K Geary; W M Fiore; C Cimino
Journal:  J Vasc Surg       Date:  1995-11       Impact factor: 4.268

9.  Inferior vena cava filter use in pregnancy: preliminary experience.

Authors:  S Gupta; D F Ettles; G J Robinson; S W Lindow
Journal:  BJOG       Date:  2008-05       Impact factor: 6.531

10.  Assessment of apparent vena caval penetration by the Greenfield filter.

Authors:  M C Proctor; L J Greenfield; K J Cho; M M Moursi; E A James
Journal:  J Endovasc Surg       Date:  1998-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.